BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6344035)

  • 41. Captopril, alone and in combination with hydrochlorothiazide, on responses to upright tilt in conscious dogs.
    Baum T; Vander Vliet G; Glennon JC
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):139-46. PubMed ID: 7030243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Different effects of captopril on blood pressure in the acute and chronic two-kidney Goldblatt hypertensive dogs.
    Ohara N; Ono H; Hashimoto K
    Jpn Circ J; 1982 Jul; 46(7):706-14. PubMed ID: 7047789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of the acetylcholinesterase inhibitors enalapril and captopril on exercise tolerance in hypertensive patients].
    Lai C; Onnis E; Pirisi R; Orani E; Soro A; Cherchi A
    Cardiologia; 1988 Feb; 33(2):211-5. PubMed ID: 2834061
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of blood pressure and plasma norepinephrine to propranolol, metoprolol and clonidine during isometric and dynamic exercise in hypertensive patients.
    Virtanen K; Jänne J; Frick MH
    Eur J Clin Pharmacol; 1982; 21(4):275-9. PubMed ID: 7056271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
    Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
    Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the chronotropic property of captopril in hypertensive patients.
    Imai Y; Abe K; Sato M; Haruyama T; Hiwatari M; Goto T; Sato K; Kasai Y; Tajima J; Yoshinaga K
    Am Heart J; 1982 Dec; 104(6):1339-45. PubMed ID: 6128916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
    Weinberger MH
    Am J Cardiol; 1982 Apr; 49(6):1542-3. PubMed ID: 7041594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise.
    Parfyonova EV; Korichneva IL; Suvorov YI; Krasnikova TL
    Health Psychol; 1988; 7 Suppl():33-52. PubMed ID: 2854050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of naloxone on the circulatory effects of captopril.
    Rubin PC; Millar JA; Sturani S; Lawrie C; Reid JL
    Br J Clin Pharmacol; 1984 Jun; 17(6):713-7. PubMed ID: 6331480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion.
    Morganti JA; Pickering TG; Lopez-Ovejero JA; Laragh JH
    J Clin Endocrinol Metab; 1980 Apr; 50(4):748-54. PubMed ID: 6245101
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension.
    Huang CM; del Greco F; Quintanilla A; Molteni A
    JAMA; 1981 Feb; 245(5):478-82. PubMed ID: 7005474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man.
    Niarchos AP; Pickering TG; Morganti A; Laragh JH
    Clin Exp Hypertens A; 1982; 4(4-5):761-89. PubMed ID: 6179660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Am Heart J; 1983 Aug; 106(2):321-8. PubMed ID: 6346849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of PG synthesis by indomethacin does not influence the exercise induced stimulation of renin-angiotensin-aldosterone system in hypertensives treated with captopril.
    Novo S; Adamo L; Nardi E; Licata G; Strano A
    Prog Clin Biol Res; 1987; 242():387-92. PubMed ID: 3313416
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of adrenergic receptor blockade on the responses to isometric handgrip: studies in normal and hypertensive subjects.
    McAllister RG
    J Cardiovasc Pharmacol; 1979; 1(2):253-63. PubMed ID: 94394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of captopril on cold pressor test responses in normotensive and hypertensive subjects.
    Zoppi A; Sudano S; Bosco L; Spata M; Fogari R
    Am J Med; 1988 Mar; 84(3A):145-7. PubMed ID: 3064592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of captopril on heart rate in several types of hypertensive patients.
    Imai Y; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1981 Feb; 133(2):243-4. PubMed ID: 7022748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.
    Kondowe GB; Copeland S; Passmore AP; Leahey WJ; Johnston GD
    Eur J Clin Pharmacol; 1987; 32(3):229-35. PubMed ID: 3297732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor.
    Laragh JH; Case DB; Atlas SA; Sealey JE
    Hypertension; 1980; 2(4):586-93. PubMed ID: 6156900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.